All Terrain Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-600
Closed -$64K 86
2020
Q4
$64K Hold
600
0.03% 94
2020
Q3
$53K Hold
600
0.02% 92
2020
Q2
$59K Sell
600
-1,000
-63% -$88K 0.02% 92
2020
Q1
$122K Buy
1,600
+1,000
+167% +$85.2K 0.05% 144
2019
Q4
$53K Buy
+600
New +$49.8K 0.02% 194
2018
Q2
Sell
-2,500
Closed -$237K 235
2018
Q1
$237K Buy
+2,500
New +$275K 0.11% 134

Other funds holding ABBV

All Terrain Financial Advisors's ABBV Position: Q1 2026 in Review

All Terrain Financial Advisors held its AbbVie (ABBV) position steady in Q1 2026 at 9,550 shares worth $2.08M. The position accounts for 0.49% of the portfolio, ranked #37.

All Terrain Financial Advisors first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.88M in Q3 2018. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • All Terrain Financial Advisors held 9,550 shares of AbbVie worth $2.08M as of Q1 2026.
  • All Terrain Financial Advisors left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.49% of All Terrain Financial Advisors's portfolio in Q1 2026, its #37 holding.
  • All Terrain Financial Advisors first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
  • All Terrain Financial Advisors's AbbVie position peaked at $3.88M in Q3 2018.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on All Terrain Financial Advisors's 13F filing for Q1 2026, filed 12 May 2026.